LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Search

CureVac NV

Closed

2.72 -3.89

Overview

Share price change

24h

Current

Min

2.7

Max

2.74

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+178.47 upside

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

CureVac NV Chart

Related News

3 lip 2024, 09:14 UTC

Acquisitions, Mergers, Takeovers

GSK to Buy CureVac's Covid-19, Flu Vaccine Rights in Up to $1.56 Billion Deal -- Update

19 gru 2023, 16:57 UTC

Major Market Movers

CureVac Shares Hit All-Time Low on German Patent Court Ruling

3 lip 2024, 14:18 UTC

Acquisitions, Mergers, Takeovers

GSK Will Pay Up to $1.5 Billion for CureVac's mRNA Vaccines -- Barrons.com

3 lip 2024, 09:38 UTC

Market Talk

CureVac Shares Surge Premarket After Expanded Licensing Deal With GSK -- Market Talk

Peer Comparison

Price change

CureVac NV Forecast

Price Target

By TipRanks

178.47% upside

12 Months Forecast

Average 7.63 USD  178.47%

High 16 USD

Low 3 USD

Based on 3 Wall Street analysts offering 12 month price targets forCureVac NV - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

3 ratings

1

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

N/A / 3.215Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Weak Bearish Evidence